ADC Therapuetics options one Chiome antibody, declines another

Chiome Bioscience Inc. (Tokyo:4583) said it received notification from ADC Therapeutics S.A. (Epalinges, Switzerland) that ADC intends to exercise its

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE